dihexa cancer risk hgf c met The HGF/c-Met Axis: A Promising Therapeutic Target in c-Met Signaling as a Therapeutic
c Met Signaling as a Therapeutic Target in Head : The Cancer Journal Anti cancer therapeutic strategies based on HGF MET, EpCAM, and tumor stromal cross talk Cancer Cell International Springer Nature Link dihexa c met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF c Met Axis in Head HGF c Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR NGF axis Cell Death & Disease
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24


